The current medical model's reliance on blanket prescriptions is flawed because individuals have unique biochemical needs that require personalized interventions.

“It's the same kind of blanket approach with the peptide industry that we're seeing right now. How would one know based on their biochemical individuality and their DNA test which peptides are good for them and which peptides may be delarious for them?”